Implanon: subdermal single rod contraceptive implant
Bhatia, P.; Nangia, S.; Aggarwal, S.; Tewari, C.
Journal of Obstetrics and Gynaecology of India 61(4): 422-425
2011
ISSN/ISBN: 0975-6434 PMID: 22851825 DOI: 10.1007/s13224-011-0066-zDocument Number: 565869
Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon. Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy. 200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months. Implanon is safe, effective, well accepted method of contraception.
Document emailed within 0-6 h
